Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)

Completed

Conditions studied: Diabetes, Retinal Disorders

In brief

The basic objective of this project is to test a modification of existing technology for monitoring the responses of the pupil to light as a method for detecting regional losses of function of the retina. The "instrument" consists of a commercially available set of goggles that monitor the eye positions and pupils using infrared light and small cameras. The signals from the monitoring cameras are collected in a computer that records how their pupils have responded to each lighting condition. Because diabetics develop damage initially to certain parts of the retina before they have more serious damage, the ultimate goal of this research is to develop a simple, noninvasive, rapid method for widespread screening of diabetics in order to identify those who may require medical attention and/or therapy for diabetic retinopathy.

Key facts

Study ID

NCT01546766

Run by

University of California, Los Angeles

People needed

315

Starts

2007-02-01

Expected to finish

2015-08-01

Last updated by the study team

2023-11-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• All subjects: must be greater than 18 years of age and capable of understanding informed consent.
• All subjects must be willing to tolerate the placement of a set of goggles on their face.
• All subjects must have visual acuities of 20/60 or better in at least one eye.
• Normal subjects must have a history of a normal eye examination within one year prior to participation in this study.
• Normal subjects must have no history of ocular disease and no history of diabetes.
• Diabetic subjects must be diagnosed with diabetes upon prior clinical examination.
• Retinal Conditions subjects must be diagnosed with a retinal pathology, hereditary or acquired.

You may not qualify if…

• Subjects with glaucoma and high myopia are specifically excluded.
• Diabetic subjects may not have had laser (panretinal photocoagulation) in both eyes.

Where it is running

• Jules Stein Eye Institute, Dept. of Ophthalmology, David Geffen School of Medicine at UCLA — Los Angeles, California, United States
• Neuro Kinetics Inc. — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.